Aliquots

April 17, 2012

Pathways to delirium in the ICU

Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.

By Leigh MacMillan
April 13, 2012

Wilms’ tumors differ in developing nations

In addition to limited health care resources, biological factors may play a role in the poor survival of children with a common kidney cancer in developing nations.

By VUMC News and Communications
April 12, 2012

Targeting post-transplant diabetes

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.

By VUMC News and Communications
April 6, 2012

Factor sensitizes cancer to radiation

Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy.

By VUMC News and Communications
April 6, 2012

New tool hooks heart failure drugs

A new screening tool – using glowing fish embryos – could identify therapeutics for myocardial hypertrophy and heart failure.

By Leigh MacMillan
April 6, 2012

Plant compound quells inflammation

Berberine, an herbal remedy for diarrhea and intestinal parasites, may be an effective treatment for gastrointestinal inflammatory diseases.

By Leigh MacMillan
April 6, 2012

Gut germs govern growth

Treating H. pylori infection in children may help their growth rebound, a recent study suggests.
By VUMC News and Communications
March 23, 2012

Smoking stokes cells’ cancer capacity

Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk.
By VUMC News and Communications
March 21, 2012

Obesity turns “good” cholesterol bad

Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol.
By Leigh MacMillan
March 19, 2012

iPOND method goes fishing for proteins

A new tool will allow researchers to identify proteins involved in DNA replication and damage repair, processes that go awry in cancer.
By Leigh MacMillan
March 16, 2012

Colon cancer’s cellular crossroads

New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.
By VUMC News and Communications
March 10, 2012

Urine biomarker for colon cancer?

A molecule detectable in urine may be helpful in diagnosing colon cancer.
By VUMC News and Communications
March 9, 2012

Combo combats dizziness

Some patients may need a combo of medications to combat a condition that causes dizziness.
By VUMC News and Communications